Cargando…

Effectiveness and cost-effectiveness of eliminating cervical cancer through a tailored optimal pathway: a modeling study

BACKGROUND: The World Health Assembly has adopted a global strategy to eliminate cervical cancer. However, neither the optimal pathway nor the corresponding economic and health benefits have been evaluated. We take China as an example to assess the optimal pathway towards elimination and the cost-ef...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xia, Changfa, Xu, Xiaoqian, Zhao, Xuelian, Hu, Shangying, Qiao, Youlin, Zhang, Yong, Hutubessy, Raymond, Basu, Partha, Broutet, Nathalie, Jit, Mark, Zhao, Fanghui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927373/ https://www.ncbi.nlm.nih.gov/pubmed/33653331 http://dx.doi.org/10.1186/s12916-021-01930-9

Ejemplares similares

Health and economic impact of delaying large-scale HPV vaccination and screening implementation on cervical cancer in China: a modelling study
por: Gao, Meng, et al.
Publicado: (2023)

Optimal allocation strategies for HPV vaccination introduction and expansion in China accommodated to different supply and dose schedule scenarios: A modelling study
por: You, Tingting, et al.
Publicado: (2022)

Cost-effectiveness of measles and rubella elimination in low-income and middle-income countries
por: Levin, Ann, et al.
Publicado: (2023)

The Potential of Adding Mammography to Handheld Ultrasound or Automated Breast Ultrasound to Reduce Unnecessary Biopsies in BI-RADS Ultrasound Category 4a: A Multicenter Hospital-Based Study in China
por: Ren, Wenhui, et al.
Publicado: (2023)

Performance of cervical cancer screening and triage strategies among women living with HIV in China
por: Duan, Rufei, et al.
Publicado: (2021)

A case study using the United Republic of Tanzania: costing nationwide HPV vaccine delivery using the WHO Cervical Cancer Prevention and Control Costing Tool
por: Hutubessy, Raymond, et al.
Publicado: (2012)

Comprehensive approach to costing cervical cancer prevention and control: a case study in the United Republic of Tanzania using the Cervical Cancer Prevention and Control Costing (C4P) tool
por: Levin, Ann, et al.
Publicado: (2022)

Value of multi-quadrants biopsy: Pooled analysis of 11 population-based cervical cancer screening studies
por: Zhao, Yuqian, et al.
Publicado: (2020)

Elimination of Cervical Cancer: Challenges Promoting the HPV Vaccine in China
por: Wei, Lihui, et al.
Publicado: (2021)

Distribution of high-risk human papillomavirus genotype prevalence and attribution to cervical precancerous lesions in rural North China
por: Zhao, Shuang, et al.
Publicado: (2019)

Effect of electronic health (eHealth) on quality of life in women with breast cancer: A systematic review and meta‐analysis of randomized controlled trials
por: Wen, Tianmeng, et al.
Publicado: (2023)

Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries
por: Brisson, Marc, et al.
Publicado: (2020)

From cervical cancer elimination to eradication of vaccine-type human papillomavirus: Feasibility, public health strategies and cost-effectiveness
por: Jit, Mark, et al.
Publicado: (2021)

Impact of HPV-16/18 AS04-adjuvanted vaccine on preventing subsequent infection and disease after excision treatment: post-hoc analysis from a randomized controlled trial
por: Zhao, Shuang, et al.
Publicado: (2020)

Role of Epstein-Barr Virus and Human Papillomavirus Coinfection in Cervical Intraepithelial Neoplasia in Chinese Women Living With HIV
por: Feng, Min, et al.
Publicado: (2021)

Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models
por: Jit, Mark, et al.
Publicado: (2011)

Methodological Challenges to Economic Evaluations of Vaccines: Is a Common Approach Still Possible?
por: Jit, Mark, et al.
Publicado: (2016)

Comparative review of three cost-effectiveness models for rotavirus vaccines in national immunization programs; a generic approach applied to various regions in the world
por: Postma, Maarten J, et al.
Publicado: (2011)

Cancer burden attributable to human papillomavirus infection by sex, cancer site, age, and geographical area in China
por: Duan, Rufei, et al.
Publicado: (2019)

Global guidelines for breast cancer screening: A systematic review()
por: Ren, Wenhui, et al.
Publicado: (2022)

Response to comment on: “Global guidelines for breast cancer screening: A systematic review”
por: Ren, Wenhui, et al.
Publicado: (2022)

Estimating the effect of HIV on cervical cancer elimination in South Africa: Comparative modelling of the impact of vaccination and screening
por: Boily, Marie-Claude, et al.
Publicado: (2022)

Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries
por: Canfell, Karen, et al.
Publicado: (2020)

Europe's Path to Eliminating Cervical Cancer as a Public Health Problem
por: Ritchie, David, et al.
Publicado: (2021)

Epidemiologic and Health Economic Evaluation of Cervical Cancer Screening in Rural China
por: Zhao, Fei, et al.
Publicado: (2020)

Generalized cost-effectiveness analysis for national-level priority-setting in the health sector
por: Hutubessy, Raymond, et al.
Publicado: (2003)

Maternal immunisation against Group B Streptococcus: A global analysis of health impact and cost-effectiveness
por: Procter, Simon R., et al.
Publicado: (2023)

High-risk HPV nucleic acid detection kit–the careHPV test –a new detection method for screening
por: Ying, Hong, et al.
Publicado: (2014)

Cancer screening in China: a steep road from evidence to implementation
por: Xia, Changfa, et al.
Publicado: (2023)

Cost-effectiveness of the screen-and-treat strategies using HPV test linked to thermal ablation for cervical cancer prevention in China: a modeling study
por: Zhao, Xue-Lian, et al.
Publicado: (2023)

Molecular triaging options for women testing HPV positive with self-collected samples
por: Taghavi, Katayoun, et al.
Publicado: (2023)

Cost–effectiveness thresholds: pros and cons
por: Bertram, Melanie Y, et al.
Publicado: (2016)

Programme costs in the economic evaluation of health interventions
por: Johns, Benjamin, et al.
Publicado: (2003)

Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative
por: Singh, Deependra, et al.
Publicado: (2022)

A review of the costs of delivering maternal immunisation during pregnancy
por: Procter, Simon R, et al.
Publicado: (2020)

Revisiting strategies to eliminate mother-to-child transmission of syphilis
por: Taylor, Melanie, et al.
Publicado: (2018)

Cervical cancer treatment costs and cost-effectiveness analysis of human papillomavirus vaccination in Vietnam: a PRIME modeling study
por: Van Minh, Hoang, et al.
Publicado: (2017)

Economic evaluation of cervical cancer screening strategies in urban China
por: Ma, Li, et al.
Publicado: (2019)

Thirty years of vaccination in Vietnam: Impact and cost-effectiveness of the national Expanded Programme on Immunization
por: Jit, Mark, et al.
Publicado: (2015)

A Road Map for the Global Elimination of Congenital Syphilis
por: Kamb, Mary L., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_m669101ssbp0c6olq16p68pd9b